News & Events: Type 1 Diabetes

The California Institute for Regenerative Medicine (CIRM) awarded $11.08 Million to Dr. Peter Stock at the University of California San Francisco (UCSF) to conduct a clinical trial for treatment of Type 1 Diabetes (T1D)... The trial will be using parathyroid glands to aid in the success and viability of the transplant procedure.  Co-transplantation of islets and parathyroid glands, from the same donor, substantially increases beta cell survival, potentially enabling adequate long-term insulin production and removing the need for multiple donors.  Additionally, the co-transplantation will [...]

Kidney failure is a debilitating and ultimately deadly illness, and a health policy crisis. With 468,000 people on dialysis in the U.S., costing the government $31 billion dollars a year, very little money is spent on researching alternatives to current treatments. Wired magazine's Megan Molteni visited Shuvo Roy, PhD, to check in on the progress of the implantable artificial kidney, which has been in the works for more than 20 years. Roy is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and [...]

The National Institute of Biomedical Imaging and Bioengineering (NIBIB), one of the National Institutes of Health, has awarded bioengineering professor Shuvo Roy, PhD, a three-year, $2.4 million grant to develop a bioartificial pancreas for treatment of Type 1 Diabetes. The project is a collaboration between the Department of Surgery, Department of Bioengineering & Therapeutic Sciences, and Diabetes Center at UCSF. Co-investigators include: Tejal Desai, PhD - Department of Bioengineering & Therapeutic Sciences Matthias Hebrok, PhD - Diabetes Center at UCSF Andrew Posselt, MD, [...]

Andrew Posselt, MD, PhD is a transplant and bariatric surgeon and professor of surgery at UCSF.  Dr. Posselt performs kidney, liver, pancreas and islet transplants. He is also among a handful surgeons in the country who also performs bariatric surgery for patients who would otherwise be transplant candidates, but for their BMI and weight.  Dr. Posselt is also director the pancreatic islet transplantation program and as a surgeon-scientist conducts breakthrough research in islet transplantation, tolerance or rejection of transplanted tissue, and the metabolic and biochemical changes seen in [...]